menu
    • menu

    Company profile for Medac

    Default Key Product, Service and Excipients
    News
    Metoject subcutaneous inj pen launches in Japan rheumatic arthritis treatment

    22 May 2024

    // BIOSPECTRUM ASIA

    Medac GmbH Advances Pharmacovigilance Technology

    13 Sep 2023

    // PR NEWSWIRE

    Glycostem, medac enter multi-purpose agreement for oNKord

    01 Aug 2022

    // PRNEWSWIRE

    DATA COMPILATION
    #PharmaFlow

    #1

    Contact Supplier

    Website

    Simposio AFI

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content

    radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Related CompaniesRelated Companies

    About

    medac GmbH has its main focus on the therapeutic areas of oncology and autoimmnune diseases. Founded in 1970 and since than privately owned, medac delivers a wide range of generic and unique products. Apart from Germany as home market, medac supplies directly or through partners to more than 70 countries all over the world. Covering nearly all major generic cancer indications and API's, medac offers EU-approved dossiers and finshed dosage forms (FDF). In addition, product devolpment is carried out together with an effiliated company located in Germany, specializing in contract manufacturing of cytotoxic agents.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MedacGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Theaterstraße 6 22880 Wedel
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.medac-group.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI China

    Not Confirmed

    envelop Contact Supplier

    CPhI China

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    NEWS #PharmaBuzz

    read-more
    read-more
    Metoject subcutaneous inj pen launches in Japan rheumatic arthritis treatment
    Metoject subcutaneous inj pen launches in Japan rheumatic arthritis treatment

    22 May 2024

    // BIOSPECTRUM ASIA

    https://www.biospectrumasia.com/news/25/24283/metoject-subcutaneous-injection-pen-launches-in-japan-for-rheumatic-arthritis-treatment.html

    BIOSPECTRUM ASIA
    22 May 2024
    Share Share
    Medac GmbH Advances Pharmacovigilance Technology
    Medac GmbH Advances Pharmacovigilance Technology

    13 Sep 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/medac-gmbh-advances-pharmacovigilance-technology-for-safety-monitoring-of-its-drugs-with-arisglobal-solutions-301925741.html

    PR NEWSWIRE
    13 Sep 2023
    Share Share
    Glycostem, medac enter multi-purpose agreement for oNKord
    Glycostem, medac enter multi-purpose agreement for oNKord

    01 Aug 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/glycostem-and-medac-enter-into-license-manufacturing-supply-and-commercialization-agreement-for-glycostems-lead-product---onkord-301596859.html

    PRNEWSWIRE
    01 Aug 2022
    Share Share
    Byondis Partners with Medac to Commercialize Antibody-Drug Conjugate
    Byondis Partners with Medac to Commercialize Antibody-Drug Conjugate

    03 May 2022

    // CONTRACTPHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2022-05-03/byondis-partners-with-medac-to-commercialize-antibody-drug-conjugate/?widget=listSection

    CONTRACTPHARMA
    03 May 2022
    Share Share
    FDA slaps back small-cap's bid to repurpose 50-year-old chemotherapy
    FDA slaps back small-cap's bid to repurpose 50-year-old chemotherapy

    04 Aug 2021

    // Jason Mast ENDPTS

    https://endpts.com/fda-slaps-back-small-caps-bid-to-repurpose-50-year-old-chemotherapy/

    Jason Mast ENDPTS
    04 Aug 2021
    Share Share
    Medexus and medac GmbH enter into Licensing Agreement for Treosulfan, in Canada
    Medexus and medac GmbH enter into Licensing Agreement for Treosulfan, in Canada

    12 Jul 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/07/12/2261295/0/en/Medexus-Pharmaceuticals-and-medac-GmbH-enter-into-Licensing-Agreement-for-First-in-Class-Conditioning-Agent-Treosulfan-in-Canada.html

    GLOBENEWSWIRE
    12 Jul 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search